PhenX - systemic lupus erythematosus protocol 171001:-:Pt: Patient:-:PhenX

Preferred Label : PhenX - systemic lupus erythematosus protocol 171001:-:Pt: Patient:-:PhenX;

LOINC status : TRIAL;

LOINC long common name : PhenX - systemic lupus erythematosus protocol 171001;

LOINC short name : Lupus SLE proto;

LOINC description : The System Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ARC) Damage Index for Systemic Lupus Erythematosus is a method that physician investigators use to determine the extent of permanent damage to various body organs or organ systems due to lupus or to the treatment thereof. This method is widely used and allows the physician to determine if a person has had any nonreversible changes (i.e., damage) to organ systems. These changes have occurred since a person is being diagnosed with lupus, are not related to active inflammation, and are ascertained via a clinical assessment. Also, unless stated otherwise, these changes must be present for at least six months prior to the assessment. The SLICC /ARC Damage Index is a cumulative index that records damage that occurs in individuals with lupus, regardless of whether the damage can be definitively attributed to lupus or is due to another cause, such as a comorbid condition. Prior to completing this protocol, the PhenX Skin, Bone, Muscle and Joint Working Group (WG) notes that investigators must first confirm the presence of lupus in respondents. This can be done via the PhenX measure Autoimmune Diseases Related to Type 1 Diabetes. This measure uses one question to determine the presence of various autoimmune diseases (including lupus) in respondents or their children.;

Details

Origin ID

64392-4;

UMLS CUI

C3173924;

Has component
- PhenX - systemic lupus erythematosus protocol 171001 [LOINC component]
Has method
- PhenX [LOINC method]
Has system
- Patient [LOINC System]
- ^Patient [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Panel of LOINC codes
- Angina or coronary artery bypass:Hx:Pt:^Patient:Ord:Reported [LOINC code]
- Avascular necrosis:Hx:Pt:^Patient:Ord:PhenX [LOINC code]
- Cardiomyopathy:Hx:Pt:^Patient:Ord:Reported [LOINC code]
- Cataract:Hx:Pt:^Patient:Ord:Reported [LOINC code]
- Cerebrovascular accident:Hx:Pt:^Patient:Ord:Reported [LOINC code]
- Chronic peritonitis:Hx:Pt:^Patient:Ord:PhenX [LOINC code]
- Claudication for 6Mo:Hx:Pt:^Patient:Ord:Reported [LOINC code]
- Cognitive impairment:Hx:Pt:^Patient:Ord:Reported [LOINC code]
- Cranial or peripheral neuropathy:Hx:Pt:^Patient:Ord:Reported [LOINC code]
- Deforming or erosive arthritis:Hx:Pt:^Patient:Ord:PhenX [LOINC code]
- Diabetes:Hx:Pt:^Patient:Ord:PhenX [LOINC code]
- End-stage renal disease:Hx:Pt:^Patient:Ord:Reported [LOINC code]
- Estimated or measured glomerular filtration rate less than 50 percent:Hx:Pt:^Patient:Ord:Reported [LOINC code]
- Extensive scarring or panniculum other than scalp and pulp space:Hx:Pt:^Patient:Ord:PhenX [LOINC code]
- Gastrointestinal Infarction or resection of bowel below duodenum, spleen, liver, or gall bladder:Hx:Pt:^Patient:Ord:PhenX [LOINC code]
- Malignancy:Hx:Pt:^Patient:Ord:PhenX [LOINC code]
- Mesenteric insufficiency:Hx:Pt:^Patient:Ord:PhenX [LOINC code]
- Minor tissue loss:Hx:Pt:^Patient:Ord:PhenX [LOINC code]
- Muscle atrophy or weakness:Hx:Pt:^Patient:Ord:PhenX [LOINC code]
- Myocardial infarction:Hx:Pt:^Patient:Ord:Reported [LOINC code]
- Osteomyelitis:Hx:Pt:^Patient:Ord:PhenX [LOINC code]
- Osteoporosis with fracture or vertebral collapse:Hx:Pt:^Patient:Ord:PhenX [LOINC code]
- Pericarditis for 6Mo, or pericardiectomy:Hx:Pt:^Patient:Ord:Reported [LOINC code]
- Pleural fibrosis:Hx:Pt:^Patient:Ord:Reported [LOINC code]
- Premature gonadal failure:Hx:Pt:^Patient:Ord:PhenX [LOINC code]
- Proteinuria greater than or equal to 3.5 gm in 24H:Hx:Pt:^Patient:Ord:Reported [LOINC code]
- Pulmonary fibrosis:Hx:Pt:^Patient:Ord:Reported [LOINC code]
- Pulmonary hypertension:Hx:Pt:^Patient:Ord:Reported [LOINC code]
- Pulmonary infarction:Hx:Pt:^Patient:Ord:Reported [LOINC code]
- Retinal change or optic atrophy:Hx:Pt:^Patient:Ord:Reported [LOINC code]
- Scarring chronic alopecia:Hx:Pt:^Patient:Ord:PhenX [LOINC code]
- Seizures requiring therapy for 6Mo:Hx:Pt:^Patient:Ord:Reported [LOINC code]
- Shrinking lung:Hx:Pt:^Patient:Ord:Reported [LOINC code]
- Significant tissue loss:Hx:Pt:^Patient:Ord:PhenX [LOINC code]
- Skin ulceration for >6Mo:Hx:Pt:^Patient:Ord:PhenX [LOINC code]
- Stricture or upper gastrointestinal tract surgery:Hx:Pt:^Patient:Ord:PhenX [LOINC code]
- Transverse myelitis:Hx:Pt:^Patient:Ord:Reported [LOINC code]
- Valvular disease:Hx:Pt:^Patient:Ord:Reported [LOINC code]
- Venous thrombosis with swelling, ulceration, or venous stasis:Hx:Pt:^Patient:Ord:PhenX [LOINC code]
Part of panel
- PhenX domain - Skin, bone, muscle and joint:-:Pt:^Patient:-:PhenX [LOINC code]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients